A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.

Benzer Materyaller

• A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
  Yazar:: Bleehen, N. M., ve diğerleri
  Baskı/Yayın Bilgisi: (1993)
• Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer.
  Yazar:: McIllmurray, M B, ve diğerleri
  Baskı/Yayın Bilgisi: (1989)
• A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
  Yazar:: Cerny, T., ve diğerleri
  Baskı/Yayın Bilgisi: (1989)
• Combination Chemotherapy with Cyclophosphamide, Vincristine, Cisplatin and Etoposide(COPE) Combined with Radiotherapy for Small Cell Lung Cancer
  Yazar:: Nam, Yong Jin, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• Feasibility of Treating Adults with Ewing or Ewing‐Like Sarcoma with Interval‐Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide
  Yazar:: Lu, Eric, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)